Skip to main content
. 2018 Jul 26;12:1337–1346. doi: 10.2147/PPA.S164406

Table 3.

Implications of dosage form modification

Instance of modification Implication
• Controlled release and sustained release formulations • Erratic/delayed absorption
• Toxic/sub-therapeutic doses
• Increased risk of side effects
• Enteric-coated formulations • Altered absorption
• Increased side effects such as gastric irritation
• Instability and inactivity of medication
• Sugar-coated formulations • Altered taste
• Film-coated formulations • Decreased adherence
• Light-sensitive formulations • Physicochemical instability
• Humidity-sensitive formulations
• Hormonal or cytotoxic medications • Occupational exposure of health care professionals
• Inhalation of drug particles
• Dermal contact
• Risk of allergies, infertility, congenital malformations, abortion
• Process of dosage form modification • Powder loss/spillage
• Inaccurate dosing
• Cross-contamination
• Physicochemical incompatibility of mixed medications